THERAKOS DEVELOPMENT LTD: GETS MDR APPROVAL IN EUROPE TO TREAT IMMUNE-RELATED ADVERSE EVENTS IN PATIENTS WITH INADEQUATE RESPONSE TO CORTICOSTEROIDS

Reuters · 2d ago

Please log in to view news